Alivus Life

{
  "main_header": {
    "sid": 1003513,
    "name": "Alivus Life",
    "stock_name": "Alivus Life",
    "full_name": "Alivus Life Sciences Ltd",
    "name_url": "stocks-analysis/alivus-life",
    "exchange": 1,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "861.30",
    "chg": -7.05,
    "chgp": "-0.81%",
    "dir": -1,
    "prev_price": "868.35",
    "mcapval": "10,551.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 543322,
    "symbol": "ALIVUS",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE03Q201024",
    "curr_date": "Jan 21",
    "curr_time": "",
    "bse_nse_vol": "1.13 lacs",
    "exc_status": "Active",
    "traded_date": "Jan 21, 2026",
    "traded_date_str": "2026 01 21",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/alivus-life-1003513-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Alivus Life Sciences Ltd: Technical Momentum Shifts Amid Mixed Indicator Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/alivus-life-sciences-ltd-technical-momentum-shifts-amid-mixed-indicator-signals-3797755",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/AlivusLifeScien_technicaldot_3797755.png",
        "date": "2026-01-21 08:04:46",
        "description": "Alivus Life Sciences Ltd has experienced a notable shift in its technical momentum, with key indicators signalling a transition from bearish to mildly bearish territory. Despite some bullish cues on shorter-term charts, the overall technical landscape remains cautious, reflecting the stock’s recent underperformance relative to the broader market and sector peers."
      },
      {
        "title": "Alivus Life Sciences Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/alivus-life-sciences-ltd-is-rated-sell-3795780",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/AlivusLifeScien_mojoScore_3795780.png",
        "date": "2026-01-20 10:10:59",
        "description": "Alivus Life Sciences Ltd is rated Sell by MarketsMOJO. This rating was last updated on 14 January 2026, reflecting a reassessment of the stock’s outlook. However, all fundamentals, returns, and financial metrics discussed here are current as of 20 January 2026, providing investors with the latest perspective on the company’s position."
      },
      {
        "title": "Alivus Life Sciences Ltd Faces Bearish Momentum Amid Technical Downgrade",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/alivus-life-sciences-ltd-faces-bearish-momentum-amid-technical-downgrade-3793784",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/AlivusLifeScien_technicaldot_3793784.png",
        "date": "2026-01-19 08:03:44",
        "description": "Alivus Life Sciences Ltd has experienced a notable shift in its technical momentum, with key indicators signalling a transition from mildly bearish to bearish trends. The stock’s recent price action, combined with mixed signals from MACD, RSI, and moving averages, suggests increasing downside pressure amid a challenging market backdrop for the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "When is the next results date for Alivus Life Sciences Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-alivus-life-sciences-ltd-3793079",
        "imagepath": "",
        "date": "2026-01-16 23:16:00",
        "description": "The next results date for Alivus Life Sciences Ltd is scheduled for 22 January 2026...."
      },
      {
        "title": "Alivus Life Sciences Ltd Faces Bearish Momentum Amid Mixed Technical Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/alivus-life-sciences-ltd-faces-bearish-momentum-amid-mixed-technical-signals-3791409",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/AlivusLifeScien_technicaldot_3791409.png",
        "date": "2026-01-14 08:03:47",
        "description": "Alivus Life Sciences Ltd has experienced a notable shift in its technical momentum, with key indicators signalling a transition from mildly bearish to bearish trends. Despite a recent upgrade in its Mojo Grade to 'Hold' from 'Sell', the stock faces downward pressure amid mixed technical signals and a challenging market backdrop."
      },
      {
        "title": "Alivus Life Sciences Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/alivus-life-sciences-ltd-is-rated-sell-3786605",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/AlivusLifeScien_mojoScore_3786605.png",
        "date": "2026-01-09 10:11:03",
        "description": "Alivus Life Sciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 01 August 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 09 January 2026, providing investors with the latest insights into its performance and outlook."
      },
      {
        "title": "Alivus Life Sciences Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/alivus-life-sciences-ltd-is-rated-sell-3772957",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/AlivusLifeScien_mojoScore_3772957.png",
        "date": "2025-12-29 10:10:52",
        "description": "Alivus Life Sciences Ltd is rated Sell by MarketsMOJO, with this rating last updated on 01 Aug 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 29 December 2025, providing investors with an up-to-date view of its fundamentals, returns, and market standing."
      },
      {
        "title": "Alivus Life Sciences Shows Mixed Technical Signals Amid Market Volatility",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/alivus-life-sciences-technical-momentum-shifts-amid-mixed-market-signals-3766547",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/AlivusLifeScien_technicaldot_3766547.png",
        "date": "2025-12-23 08:18:07",
        "description": "Alivus Life Sciences, a key player in the Pharmaceuticals & Biotechnology sector, is currently exhibiting a complex technical profile as recent market data reveals a nuanced shift in price momentum and indicator signals. The stock’s performance contrasts with broader market trends, reflecting a period of consolidation and cautious investor sentiment."
      },
      {
        "title": "Alivus Life Sees Revision in Market Evaluation Amidst Challenging Sector Dynamics",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/alivus-life-downgraded-to-sell-by-marketsmojo-amid-weak-financial-and-technical-signals-3762207",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/AlivusLife_mojoScore_3762207.png",
        "date": "2025-12-18 10:10:41",
        "description": "Alivus Life, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a revision in its market evaluation reflecting shifts in key analytical parameters. This adjustment comes amid subdued financial trends and technical indicators, highlighting the challenges faced by the company in a competitive and evolving industry landscape."
      }
    ],
    "total": 249,
    "sid": "1003513",
    "stock_news_url": "https://www.marketsmojo.com/news/alivus-life-sciences-1003513"
  },
  "announcements": "",
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "",
      "data": [
        {
          "title": "BOARD MEETING",
          "txt": "22 Jan 2026"
        }
      ]
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Alivus Life Sciences Ltd has declared <strong>250%</strong> dividend, ex-date: 01 Sep 25",
          "dt": "2025-09-01",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Alivus Life Sciences Ltd: Technical Momentum Shifts Amid Mixed Indicator Signals

2026-01-21 08:04:46

Alivus Life Sciences Ltd has experienced a notable shift in its technical momentum, with key indicators signalling a transition from bearish to mildly bearish territory. Despite some bullish cues on shorter-term charts, the overall technical landscape remains cautious, reflecting the stock’s recent underperformance relative to the broader market and sector peers.

Read full news article

Alivus Life Sciences Ltd is Rated Sell

2026-01-20 10:10:59

Alivus Life Sciences Ltd is rated Sell by MarketsMOJO. This rating was last updated on 14 January 2026, reflecting a reassessment of the stock’s outlook. However, all fundamentals, returns, and financial metrics discussed here are current as of 20 January 2026, providing investors with the latest perspective on the company’s position.

Read full news article

Alivus Life Sciences Ltd Faces Bearish Momentum Amid Technical Downgrade

2026-01-19 08:03:44

Alivus Life Sciences Ltd has experienced a notable shift in its technical momentum, with key indicators signalling a transition from mildly bearish to bearish trends. The stock’s recent price action, combined with mixed signals from MACD, RSI, and moving averages, suggests increasing downside pressure amid a challenging market backdrop for the Pharmaceuticals & Biotechnology sector.

Read full news article

When is the next results date for Alivus Life Sciences Ltd?

2026-01-16 23:16:00

The next results date for Alivus Life Sciences Ltd is scheduled for 22 January 2026....

Read full news article

Alivus Life Sciences Ltd Faces Bearish Momentum Amid Mixed Technical Signals

2026-01-14 08:03:47

Alivus Life Sciences Ltd has experienced a notable shift in its technical momentum, with key indicators signalling a transition from mildly bearish to bearish trends. Despite a recent upgrade in its Mojo Grade to 'Hold' from 'Sell', the stock faces downward pressure amid mixed technical signals and a challenging market backdrop.

Read full news article

Alivus Life Sciences Ltd is Rated Sell

2026-01-09 10:11:03

Alivus Life Sciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 01 August 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 09 January 2026, providing investors with the latest insights into its performance and outlook.

Read full news article

Alivus Life Sciences Ltd is Rated Sell

2025-12-29 10:10:52

Alivus Life Sciences Ltd is rated Sell by MarketsMOJO, with this rating last updated on 01 Aug 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 29 December 2025, providing investors with an up-to-date view of its fundamentals, returns, and market standing.

Read full news article

Alivus Life Sciences Shows Mixed Technical Signals Amid Market Volatility

2025-12-23 08:18:07

Alivus Life Sciences, a key player in the Pharmaceuticals & Biotechnology sector, is currently exhibiting a complex technical profile as recent market data reveals a nuanced shift in price momentum and indicator signals. The stock’s performance contrasts with broader market trends, reflecting a period of consolidation and cautious investor sentiment.

Read full news article

Alivus Life Sees Revision in Market Evaluation Amidst Challenging Sector Dynamics

2025-12-18 10:10:41

Alivus Life, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a revision in its market evaluation reflecting shifts in key analytical parameters. This adjustment comes amid subdued financial trends and technical indicators, highlighting the challenges faced by the company in a competitive and evolving industry landscape.

Read full news article

View All News